Aromatase inhibition plus/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II study
芳香化酶抑制剂联合/不联合Src抑制剂沙拉替尼(AZD0530)治疗晚期乳腺癌(ARISTACAT):一项随机II期研究
期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-023-06873-8
Oswald, Ailsa J; Symeonides, Stefan N; Wheatley, Duncan; Chan, Stephen; Brunt, Adrian Murray; McAdam, Karen; Schmid, Peter; Waters, Simon; Poole, Christopher; Twelves, Chris; Perren, Timothy; Bartlett, John; Piper, Tammy; Chisholm, Eve Macdonald; Welsh, Michelle; Hill, Robert; Hopcroft, Lisa E M; Barrett-Lee, Peter; Cameron, David A